Growth Metrics

West Pharmaceutical Services (WST) Current Taxes (2016 - 2026)

West Pharmaceutical Services has reported Current Taxes over the past 18 years, most recently at $78.9 million for Q1 2026.

  • Quarterly Current Taxes rose 253.81% to $78.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $78.9 million through Mar 2026, up 253.81% year-over-year, with the annual reading at $28.1 million for FY2025, 10.79% down from the prior year.
  • Current Taxes was $78.9 million for Q1 2026 at West Pharmaceutical Services, up from $28.1 million in the prior quarter.
  • Over five years, Current Taxes peaked at $78.9 million in Q1 2026 and troughed at $15.0 million in Q3 2023.
  • The 5-year median for Current Taxes is $28.5 million (2025), against an average of $31.1 million.
  • Biggest five-year swings in Current Taxes: tumbled 71.53% in 2024 and later skyrocketed 253.81% in 2026.
  • Tracing WST's Current Taxes over 5 years: stood at $24.8 million in 2022, then plummeted by 33.06% to $16.6 million in 2023, then surged by 89.76% to $31.5 million in 2024, then fell by 10.79% to $28.1 million in 2025, then soared by 180.78% to $78.9 million in 2026.
  • According to Business Quant data, Current Taxes over the past three periods came in at $78.9 million, $28.1 million, and $33.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.